Hi all. You know, I've been wondering about how much implied efficacy there could be with 2591 after the 2566 results. I mean, what degree of similarity is there in the science of both compounds and factors such as the positive safety profile? I have been optimistic about the prospects of these phase II trials, particularly given Jon's excitement, given he is so careful and conservative. It just adds to the intrigue of it all. What a fantastic journey it has been so far. I hope the briefing has been a great opportunity for some loyal holders to catch up and celebrate the DayBue approval milestone over a drink or two. Cheers.
Hi all. You know, I've been wondering about how much implied...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.70 |
Change
0.520(2.71%) |
Mkt cap ! $2.515B | |||
| Open | High | Low | Value | Volume |
| $19.39 | $19.84 | $19.28 | $5.675M | 288.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1531 | $19.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.81 | 557 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.70 |
Change
0.520 ( 2.59 %) |
||||
| Open | High | Low | Volume | ||
| $19.50 | $19.84 | $19.28 | 87628 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| NEU (ASX) Chart |